Breaking Gene Therapy News

Ziopharm slips 1% after hours following release of early-stage data on gene therapy Controlled IL-12

Nov 16, 2018 | 22:34 pm

Ziopharm slips 1% after hours following release of early-stage data on gene therapy Controlled IL-12 Seeking AlphaFull coverage

Hope for sickle cell disease patients after promising gene therapy breakthrough

Nov 16, 2018 | 20:41 pm

Hope for sickle cell disease patients after promising gene therapy breakthrough inews.co.ukFull coverage

Manufacturing Challenges Limit Gene Therapy Development

Nov 16, 2018 | 20:04 pm

Manufacturing Challenges Limit Gene Therapy Development BioPharm InternationalFull coverage

Gottlieb pushes for funding to speed gene therapy reviews

Nov 16, 2018 | 18:11 pm

Gottlieb pushes for funding to speed gene therapy reviews STATFull coverage

Newly published model of FSHD and a potential gene therapy to improve functional outcomes

Nov 16, 2018 | 16:52 pm

Newly published model of FSHD and a potential gene therapy to improve functional outcomes EurekAlert (press release)Full coverage

Lori Kunkel takes acting CMO role at gene therapy firm Tocagen

Nov 16, 2018 | 15:37 pm

Lori Kunkel takes acting CMO role at gene therapy firm Tocagen FierceBiotechFull coverage

A grandpa's hope for hemophilia cure leads him to gene therapy clinical trial

Nov 16, 2018 | 14:22 pm

A grandpa's hope for hemophilia cure leads him to gene therapy clinical trial CNBCFull coverage

Big pharma companies vie for hemophilia gene therapy breakthrough

Nov 16, 2018 | 13:45 pm

Big pharma companies vie for hemophilia gene therapy breakthrough CNBCFull coverage

UniQure skyrockets on haemophilia B gene therapy data

Nov 16, 2018 | 11:50 am

UniQure skyrockets on haemophilia B gene therapy data PMLiVEuniQure leaps on positive mid-stage data for gene therapy The Pharma LetterUniqure NV (NASDAQ:QURE) Rockets Higher on Emerging Phase 2 Data FDA HeadlinesFull coverage

California's gene therapy effort is nation's first

Nov 15, 2018 | 22:53 pm

California's gene therapy effort is nation's first Capitol WeeklyGlobal Primary Cell Culture Market Outlook to 2025: Expected to Grow at a CAGR of 10.6% - ResearchAndMarkets.com Business Wire (press release)After 20 years, stem cells mean business in Wisconsin University of Wisconsin-MadisonFull coverage

The sandbox: Parker Institute throws its research muscle behind gene therapy tech for destroying cancer cells

Nov 15, 2018 | 16:00 pm

The sandbox: Parker Institute throws its research muscle behind gene therapy tech for destroying cancer cells Endpoints NewsFull coverage

New Data Starts Stretch Run for UniQure's Upgraded Hemophilia Gene Therapy

Nov 15, 2018 | 13:00 pm

New Data Starts Stretch Run for UniQure's Upgraded Hemophilia Gene Therapy XconomyUniQure's hemophilia B gene therapy achieves 31% FIX activity FierceBiotechThis Biotech Just Rocketed 35% On Its Pfizer-Rivaling Gene Therapy Investor's Business DailyFull coverage

Urocortin 3 gene therapy increases systolic and diastolic function in heart failure

Nov 14, 2018 | 19:29 pm

Urocortin 3 gene therapy increases systolic and diastolic function in heart failure EurekAlert (press release)Full coverage

Biomanufacturing: These 30 gene-therapy firms employ more than 3000 in Philly area

Nov 14, 2018 | 18:45 pm

Biomanufacturing: These 30 gene-therapy firms employ more than 3000 in Philly area Philly.com (blog)Full coverage

Can Gene Therapy Deliver on its Promise?

Nov 14, 2018 | 17:10 pm

Can Gene Therapy Deliver on its Promise? Pharmaceutical Technology MagazineFull coverage

Gene Therapy That Lowered SOD1 Protein in Primates Could Be Effective in ALS, Study Suggests

Nov 14, 2018 | 15:30 pm

Gene Therapy That Lowered SOD1 Protein in Primates Could Be Effective in ALS, Study Suggests ALS News TodayFull coverage

Combination gene therapy more effective in cartilage preservation in osteoarthritis

Nov 13, 2018 | 18:15 pm

Combination gene therapy more effective in cartilage preservation in osteoarthritis EurekAlert (press release)Full coverage

Novartis' $4 Million Gene Therapy -- Real Price Or A Negotiation Ploy?

Nov 13, 2018 | 13:29 pm

Novartis' $4 Million Gene Therapy -- Real Price Or A Negotiation Ploy? ForbesFull coverage

Krystal Biotech: An Intriguing Gene Therapy Platform Play

Nov 13, 2018 | 06:07 am

Krystal Biotech: An Intriguing Gene Therapy Platform Play Seeking AlphaFull coverage

Two sick children and a $1.5 million bill: One family's race for a gene therapy cure

Oct 23, 2018 | 11:01 am

Two sick children and a $1.5 million bill: One family's race for a gene therapy cure MIT Technology ReviewFull coverage

Main Menu

Login

Related Links